y continues its belt-tightening. Also helping earnings was an increase in "other income" to $611 million from $3.8 million a year ago. That was mainly from the sale of high blood pressure drug Bystolic to Forest Laboratories Inc. for $357 million during the quarter. Total U.S. revenue fell 5 percent to $7.22 billion. That decline was offset by a 4 percent rise in international sales, mostly in North and South America outside the U.S. Revenue rose 1.2 percent for prescription drugs to $6.13 billion as sales from new medicines made up for lower sales from two medicines that got generic competition last spring,toms shoes sale, Levaquin for serious infections and Concerta for attention deficit disorder,toms outlet. But revenue was down in J J's other two businesses. Sales of medical devices and diagnostic equipment, the company's biggest segment, slipped 0.3 percent to $6.41 billion. Consumer product sales fell 2.4 percent to $3.6 billion, due to the many products still not back in stores. Your comment will be posted immediately, unless it is spam or contains profanity. For more information, please see our Comments FAQ. An insider's guide to politics and policy, available on the iPad or as a PDF download.
By MICHAEL LIEDTKE, Associated Press SAN FRANCISCO (AP) Oracle CEO Larry Ellison wanted to compete against Google's Android software in the smartphone market before deciding instead to sue his potential rival for copyright and patent infringement. Ellison acknowledged Oracle's interest in diversifying beyond its main business of database software while testifying Tuesday on the second day of a trial pitting two high-tech bellwethers. Before backing off the idea, Ellison said Oracle considered buying a smartphone maker, including Palm Inc,toms shoes sale. and BlackBerry maker Research in Motion Ltd. Palm ended up getting sold to Hewlett-Packard Co. for about $1 billion two years ago, while RIM is trying to recover from huge losses that have piled up as the BlackBerry got battered by Apple Inc.'s iPhone and handsets running on Android. "I had an idea that we could enter the smartphone business and compete with everyone in the smartphone business," Ellison testified under questioning from a Google lawyer. "It was an idea I wanted to explore. We explored it and decided it was a bad idea." Ellison, a colorful CEO who ranks among the world's richest people, took the stand after Google sought in opening statements to frame the case as Oracle's response to its own failure to build mobile software. Google CEO Larry Page also took the stand toward the end of Tuesday's session. The trial was expected to last up to 10 weeks. The dispute before a 12-person jury in U.S. District Court in San Francisco is over whether Google built its widely used Android software by improperly taking some of the technology from Java, a programming platform that Sun Microsystems began developing 20 years ago. Oracle acquired the rights to Java when it bought Sun for $7.3 billion in January 2010. Although Oracle has spent more money buying other companies, Ellison depicted Java a Related articles:

• cheaptomsshoessalei.com available on the iPad or as a PDF download.
• cheaptomsshoessalei.com PepsiCo
• tomsoutletsalecheap.com AP